期刊文献+

难治性特发性血小板减少型紫癜脾切除的临床分析 被引量:1

Clinical analysis of splenectomy for treatment of refractory idiopathic thrombocytopenic purpura
原文传递
导出
摘要 目的:探讨脾切除对难治性特发性血小板减少性紫癜的治疗效果及影响因素。方法:回顾15年中行脾切除术治疗难治性ITP患者62例的临床资料,分析年龄、性别、术前有无出血、术前对激素的反应、脾脏是否肿大、术后血小板峰值与脾切除疗效之间的关系。结果:62例中,显效34例,良效13例,进步10例,无效5例;有效率(显效+良效)为75.8%。性别和脾脏是否肿大与脾切除术疗效无关(均P>0.05);有无出血症状、年龄、术后血小板峰值、骨髓巨核细胞数等因素分组间差异具有统计学意义(均P<0.05);多因素分析表明,术前对激素的反应及术前血小板计数对脾切除疗效是主要的影响因素(均P<0.05)。结论:术前对激素的反应及术前血小板计数可作为脾切除术的疗效预测指标。 Objective: To investigate the efficacy of splenectomy for refractory idiopathic thrombocytopenic purpura (ITP) and its affecting factors. Methods: The clinical data of 62 patients with refractory ITP undergoing splenectomy over 15 years were reviewed, and the relations of the efficacy of splenectomy with age gender, preoperative bleeding, preoperative response to hormone treatment, spleen enlargement, and platelet peak were analyzed. Results: Of the 62 patients, 34 were very effective cases, 13 were favorably effective cases, 10 cases were improved, and 5 cases were completely ineffective. The efficacy rate ( very effective cases plus favorably effective cases) was 75.8%. The efficacy of splenectomy was unrelated to gender and whether the spleen was enlarged (both P〈0.05). However, the differences between the groups classified according to whether the patients had bleeding symptoms, age, postoperative platelet peak and bone marrow megakaryocyte count had statistical significance. Multivariate analysis indicated that preoperative hormone response and preoperative platelet count were the main factors affecting the efficacy of splenectomy for refractory ITP (both P〈0.05). Conclusion: Preoperative hormone response and preoperative platelet count can be used as the prediction indexes for the efficacy of splenectomy in patients with refractory ITP.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第6期700-703,共4页 China Journal of General Surgery
关键词 紫癜 血小板减少性 特发性/外科学 脾切除术 预后 Purpura, Thrombocytopenic, Idiopathic/surg Splenectomy Prognosis
  • 相关文献

参考文献10

二级参考文献36

共引文献585

同被引文献14

  • 1Tabata R,Tabata C,Kita Y.Management of myocardial in- farction in immune thrombocytopenic purpura with anti- phospholipid antibodies[J].J Thromb Thrombolysis, 2013,35 (1):115-118.
  • 2Elhoseiny SM,Morgan DS,Elhadidy KE.The association of lymphoid protein tyrosine phosphatase non-receptor 22 (PTPN 22) gene potymorphism with Egyptian immune thrombocytopenic purpura[J].Comparative Clin Pathol,2013, 22(3) :395-402.
  • 3Talaat RM, Elmaghraby AM, Barakat SS, et al.Aherations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP)[J].Clin Exp Immunol, 2014, 176(2) :291-300.
  • 4Stotler BA,Schwartz J.How we use WinRho in patients with idiopathic thrombocytopenic purpura[J].Transfusion,2016, 55 (11 ) : 2547-2550.
  • 5Rijcken E, Mees ST, Bisping G,et d.Laparoscopic splenec- tomy for medically refractory immune thrombocytopenia (ITP) :a retrospective cohort study on longtime response predicting factors based on consensus criteria[J].Int J Surg, 2014,12(12) : 1428-1433.
  • 6Martin Amau B,Turrado Rodriguez V,Tartaglia E,et al. Impact of preoperative p|atelet count on perioperative out- come after laparoscopic splenectomy for idiopathic throm- bocytopenic purpura[J].Cir Esp, 2016,94 (7) : 399-403.
  • 7Seong RH.Rapidly calcified all of multiple intracranial hemorrhages occurred in a patient with chronic idiopathic thrombocytopenic purpura [J].Interdisciplinary Neurosurg, 2016,3(5) : 1024-0129.
  • 8Tsai CH,Bussel JB,Imahiyerobo AA,et al.Platelet count control in immune thrombocytopenic purpura patient:opti- mum romiplostim dose profile[J].J Process Control,2016, 45(45) : 1147-1151.
  • 9马利锋,康建省,李涛,张立超.腹腔镜脾切除术治疗115例免疫性血小板减少症的疗效分析[J].重庆医学,2014,43(10):1199-1200. 被引量:9
  • 10曹卫刚,邱宝安.腹腔镜脾切除治疗特发性血小板减少性紫癜九例体会[J].中华普外科手术学杂志(电子版),2014,8(2):68-70. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部